Monday, November 23, 2009

ADHD Home>
ADHD News>
Clinical trial: Treatment of ADHD and dyslexia with Atomoxetine

Font size
- A
- A
- A
Email This

Bookmark

Save

Clinical trial: Treatment of ADHD and dyslexia with Atomoxetine

(National Institutes of Health) UPDATED 2009-07-07

This is a Phase 4 clinical trial to determine the effectiveness of using atomoxetine in children age 10 to 16 who have ADHD as well as dyslexia. The study will assess the effect of atomoxetine on basic reading skills,working memory, social, emotional, cognitive, educational, and affiliative functioning. This study is currently recruiting patients. Read full story >

See all ADHD News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on ADHDCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.